(Q35573894)

8 August 2017

1 reference

title

Primary biliary cirrhosis--presentation and diagnosis (English)

1 reference

8 August 2017

Primary biliary cirrhosis—presentation and diagnosis (English)

1 reference

https://api.crossref.org/works/10.1016/S1089-3261(03)00101-6

primary biliary cholangitis

27 March 2024

main subject

0 references

author name string

Ulrich Leuschner

1

1 reference

8 August 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14594129

27 March 2024

publication date

1 November 2003

1 reference

full work available at URL

8 August 2017

https://api.elsevier.com/content/article/PII:S1089326103001016?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S1089-3261(03)00101-6

https://api.elsevier.com/content/article/PII:S1089326103001016?httpAccept=text/plain

27 March 2024

1 reference

https://api.crossref.org/works/10.1016/S1089-3261(03)00101-6

27 March 2024

published in

Clinics in liver disease

1 reference

8 August 2017

volume

7

1 reference

8 August 2017

issue

4

1 reference

8 August 2017

page(s)

741-758

1 reference

Diminished survival in asymptomatic primary biliary cirrhosis. A prospective study

8 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900101-6

7 January 2021

Factors of prognostic importance in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900101-6

7 January 2021

Natural history of early primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900101-6

7 January 2021

Comparison of the clinical features and clinical course of antimitochondrial antibody-positive and -negative primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900101-6

7 January 2021

The prevalence and clinical spectrum of primary biliary cirrhosis in a defined population.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900101-6

7 January 2021

The natural history of primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900101-6

7 January 2021

Epidemiology and natural history of primary biliary cirrhosis in a US community

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900101-6

7 January 2021

Primary biliary cirrhosis once rare, now common in the United Kingdom?

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900101-6

7 January 2021

Primary biliary cirrhosis: survival of a cohort followed for 10 years

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900101-6

7 January 2021

Primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900101-6

7 January 2021

Primary biliary cirrhosis. Observations on the natural course of the disease in 25 women

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900101-6

7 January 2021

Primary biliary cirrhosis: clinical features and outcome, with special reference to asymptomatic disease

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900101-6

7 January 2021

The Presentation and Diagnosis of 100 Patients with Primary Biliary Cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900101-6

7 January 2021

The demography of primary biliary cirrhosis in Ontario, Canada

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900101-6

7 January 2021

The true impact of fatigue in primary biliary cirrhosis: a population study

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900101-6

7 January 2021

Validation of a fatigue impact score in primary biliary cirrhosis: towards a standard for clinical and trial use.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900101-6

7 January 2021

Fatigue in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900101-6

7 January 2021

Measuring the functional impact of fatigue: initial validation of the fatigue impact scale.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900101-6

7 January 2021

Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900101-6

7 January 2021

Primary biliary cirrhosis: symptomatic treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900101-6

7 January 2021

The "Butterfly" Sign in Patients with Chronic Jaundice and Pruritus

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900101-6

7 January 2021

Primary biliary cirrhosis: survival of a large cohort of symptomatic and asymptomatic patients followed for 24 years

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900101-6

7 January 2021

Bone loss and reduced osteoblast function in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900101-6

7 January 2021

Primary biliary cirrhosis in men

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900101-6

7 January 2021

Xanthomatous neuropathy in primary biliary cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900101-6

7 January 2021

The prognostic importance of clinical and histologic features in asymptomatic and symptomatic primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900101-6

7 January 2021

Portal hypertension in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900101-6

7 January 2021

Portal hypertension in primary biliary cirrhosis. Relationship with histological features

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900101-6

7 January 2021

Prospective evaluation of esophageal varices in primary biliary cirrhosis: development, natural history, and influence on survival

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900101-6

7 January 2021

Bone disease in cholestatic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900101-6

7 January 2021

Bone disease in primary biliary cirrhosis: independent indicators and rate of progression.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900101-6

7 January 2021

Risk factors for the development of vertebral and total skeleton osteoporosis in patients with primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900101-6

7 January 2021

Metabolic bone disease in primary biliary cirrhosis at presentation

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900101-6

7 January 2021

Osteoporosis in primary biliary cirrhosis revisited

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900101-6

7 January 2021

Intestinal absorption of 25-hydroxyvitamin D and osteomalacia in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900101-6

7 January 2021

Bone disease and calcium absorption in primary biliary cirrhosis with special reference to vitamin-D therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900101-6

7 January 2021

Incidence of primary liver cancer and aetiological aspects: a study of a defined population from a low-endemicity area

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900101-6

7 January 2021

Hepatocellular carcinoma in primary biliary cirrhosis and its impact on outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900101-6

7 January 2021

Hepatocellular carcinoma and survival in patients with primary biliary cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900101-6

7 January 2021

Hepatic and extrahepatic malignancies in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900101-6

7 January 2021

Primary biliary cirrhosis and ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900101-6

7 January 2021

Primary biliary cirrhosis and chronic pancreatitis in a patient with ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900101-6

7 January 2021

Does primary biliary cirrhosis in men differ from primary biliary cirrhosis in women?

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900101-6

7 January 2021

Autoimmune cholangitis within the spectrum of autoimmune liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900101-6

7 January 2021

The variant forms of autoimmune hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900101-6

7 January 2021

Autoimmune overlap syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900101-6

7 January 2021

Mitochondrial antigen/antibody systems in primary biliary cirrhosis: revisited

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900101-6

7 January 2021

Does antimitochondrial antibody status affect response to treatment in patients with primary biliary cirrhosis? Outcomes of ursodeoxycholic acid therapy and liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900101-6

7 January 2021

Positive antimitochondrial antibody but normal alkaline phosphatase: is this primary biliary cirrhosis?

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900101-6

7 January 2021

Quantitative measurement of autoantibodies to recombinant mitochondrial antigens in patients with primary biliary cirrhosis: relationship of levels of autoantibodies to disease progression

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900101-6

7 January 2021

The antinuclear autoantibodies Sp100 and gp210 persist after orthotopic liver transplantation in patients with primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900101-6

7 January 2021

Autoantibodies against a 210 kDa glycoprotein of the nuclear pore complex as a prognostic marker in patients with primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900101-6

7 January 2021

Is serum bilirubin concentration the only valid prognostic marker in primary biliary cirrhosis?

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900101-6

7 January 2021

Clinical and biochemical expression of the histopathological lesions of primary biliary cirrhosis. UDCA-PBC Group

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900101-6

7 January 2021

Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900101-6

7 January 2021

Primary biliary cirrhosis: natural history

13

1 reference

https://api.crossref.org/works/10.1016/S1089-3261(03)00101-6

27 March 2024

Cholestatic pruritus

34

1 reference

https://api.crossref.org/works/10.1016/S1089-3261(03)00101-6

Ursodeoxycholic acid delays the onset of esophageal varices in primary biliary cirrhosis

27 March 2024

50

1 reference

https://api.crossref.org/works/10.1016/S1089-3261(03)00101-6

Factors influencing the development of metabolic bone disease in primary biliary cirrhosis

27 March 2024

60

1 reference

https://api.crossref.org/works/10.1016/S1089-3261(03)00101-6

Bone disease in primary biliary cirrhosis: does ursodeoxycholic acid make a difference?

27 March 2024

61

1 reference

https://api.crossref.org/works/10.1016/S1089-3261(03)00101-6

27 March 2024

Identifiers

1 reference

8 August 2017

1 reference